WHO ICTRP trial
Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate…
JPRN-UMIN000017042 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000017042 |
|---|---|
| Public title | Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate /vilanterol fixed-dose treatment of asthma on airway inflammation with adult asthma in 4-week treatment;Open-label, randomized, parallel-group comparative study |
| Scientific title | Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate /vilanterol fixed-dose treatment of asthma on airway inflammation with adult asthma in 4-week treatment;Open-label, randomized, parallel-group comparative study - Budesonide/formoterol maintenance reliever therapy versus… |
| Primary sponsor | Hiroshima Allergy and Respiratory Clinic |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Bronchial asthma |
| Interventions | Budesonide160 mcg/Formoterol4.5 mcg once 2 inhalation,twice daily Fluticasone furoate100 mcg /vilanterol2 mcg once 1 inhalation,once daily |
| Registration date | Apr 4, 2015 |
| Target size | 30 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: